{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-021220","form_type":"8-K","ticker":"DMAC","cik":"0001401040","company_name":"DiaMedica Therapeutics Inc.","filed_at":"2024-06-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.247374+00:00","generated_at":"2026-06-01T01:23:59.533932+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"DiaMedica raises $11.8M in private placement at $2.50/share; funds stroke and preeclampsia trials","bullets":["Gross proceeds $11.8M from sale of 4.72M shares at $2.50/share; expected close June 28, 2024.","Net proceeds to fund DM199 phase 2/3 ReMEDy2 trial for acute ischemic stroke and expansion into preeclampsia.","Cash runway extended into Q3 2026.","Non-management related parties committed $6.0M (2.4M shares); exempt from MI 61-101 valuation and minority approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-021220","json":"https://secwatch.observer/filing/0001437749-24-021220.json","markdown":"https://secwatch.observer/filing/0001437749-24-021220.md","text":"https://secwatch.observer/filing/0001437749-24-021220.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401040/000143774924021220/0001437749-24-021220-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401040/000143774924021220/dmtp20240625_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T01:23:59.533932+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}